Advertisement
Advertisement

MTVA

M

MetaVia Inc.

1.85
USD
-0.3986
-17.73%
Dec 18, 15:59 UTC -5
Closed
...

MetaVia Inc. Profile

About

MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc., formerly known as NeuroBo Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Hyung Heon Kim

Headquarters

545 Concord Avenue, Suite 210
Cambridge, MA 02138, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

52

Employees

8

MetaVia Inc. Statistics

Valuation Measures

Market Capitalization2

15.95M

Enterprise Value

-5.72M

Enterprise Value/EBITDA(ttm)

0.20

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.39

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-189.12%

Return on Invested Capital(ttm)

-195.19%

Return on Assets(ttm)

-122.31%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-28.87M

Net Income Available to Common(ttm)

-27.73M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

-0.25

52-Week Change

-52.81%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

8.62M

Dividend Yield

0.00%

Float4

8.53M

% Held by Insiders

1.05%

% Held by Institutions

1.37%

Balance Sheet

Total Cash(mrq)

21.67M

Total Cash Per Share(mrq)

2.51

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.41%

Quick Ratio(mrq)

2.41%

Book Value Per Share(mrq)

1.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.89

Free Cash Flow(ytd)

-19.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement